Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review

Journal of Bone and Mineral Research

Volumn 28, Issue 8, 2013, Pages 1701-1717

  Rubin, Katrine Hass ^a,b   Friis Holmberg, Teresa ^c   Hermann, Anne Pernille ^b   Abrahamsen, Bo ^a,d   Brixen, Kim ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

osteoporotic fracture; risk assessment tools; screening; systematic review; women

Indexed keywords

CHECKLIST; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COMPARATIVE STUDY; DATA ANALYSIS; DATA EXTRACTION; FRAGILITY FRACTURE; HUMAN; INTERMETHOD COMPARISON; POPULATION RESEARCH; PREDICTION; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SYSTEMATIC REVIEW; VALIDATION PROCESS;

EID: 84881262031     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1956     Document Type: Review

References (117)

1. Sambrook P, Cooper C., Osteoporosis. Lancet. 2006; 367: 2010-8.
2. Mossey JM, Mutran E, Knott K, Craik R., Determinants of recovery 12 months after hip fracture: the importance of psychosocial factors. Am J Public Health. 1989; 79: 279-86.
3. Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B., Mortality after osteoporotic fractures. Osteoporos Int. 2004; 15: 38-42.
4. Kanis JA, Johnell O., Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int. 2005; 16: 229-38.
5. Vestergaard P, Rejnmark L, Mosekilde L., Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005; 16: 134-41.
6. Rubin KH, Abrahamsen B, Hermann AP, Bech M, Gram J, Brixen K., Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int. 2011; 22: 1401-9.
7. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R., Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010; 153: 99-111.
8. U.S., Preventive Services Task Force. Screening for osteoporosis: U.S. preventive Services Task Force recommendation statement. Ann Intern Med. 2011; 154: 356-64.
9. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 1033-46.
10. Hippisley-Cox J, Coupland C., Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009; 339: b4229.
11. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV., Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int. 2007; 18: 1109-17.
12. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV., Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int. 2008; 19: 1431-44.
13. Sambrook PN, Flahive J, Hooven FH, Boonen S, Chapurlat R, Lindsay R, Nguyen TV, Diez-Perez A, Pfeilschifter J, Greenspan SL, Hosmer D, Netelenbos JC, Adachi JD, Watts NB, Cooper C, Roux C, Rossini M, Siris ES, Silverman S, Saag KG, Compston JE, LaCroix A, Gehlbach S., Predicting fractures in an international cohort using risk factor algorithms without BMD. J Bone Miner Res. 2011; 26: 2770-7.
14. Tanaka S, Kuroda T, Saito M, Shiraki M., Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women. J Bone Miner Res. 2011; 26: 2778-84.
15. Cummins NM, Poku EK, Towler MR, O'Driscoll OM, Ralston SH., Clinical risk factors for osteoporosis in Ireland and the UK: a comparison of FRAX and QFractureScores. Calcif Tissue Int. 2011; 89: 172-7.
16. Bolland MJ, Siu AT, Mason BH, Horne AM, Ames RW, Grey AB, Gamble GD, Reid IR., Evaluation of the FRAX and Garvan fracture risk calculators in older women. J Bone Miner Res. 2011; 26: 420-7.
17. Sandhu SK, Nguyen ND, Center JR, Pocock NA, Eisman JA, Nguyen TV., Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int. 2010; 21: 863-71.
18. Collins GS, Michaelsson K., Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?. Curr Osteoporos Rep. 2012; 10: 199-207.
19. Mallett S, Royston P, Waters R, Dutton S, Altman DG., Reporting performance of prognostic models in cancer: a review. BMC Med. 2010; 8: 21.
20. Meads C, Ahmed I, Riley RD., A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012; 132: 365-77.
21. Collins GS, Mallett S, Omar O, Yu LM., Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011; 9: 103.
22. Perel P, Edwards P, Wentz R, Roberts I., Systematic review of prognostic models in traumatic brain injury. BMC Med Inform Decis Mak. 2006; 6: 38.
23. Moher D, Liberati A, Tetzlaff J, Altman DG., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8: 336-41.
24. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J., The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25.
25. Diagnostic Test Accuracy Working Group, The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy, version 1.0.1. Chichester, UK: John Wiley & Sons; 2009.
26. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J., Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006; 6: 9.
27. Tanprasertkul C, Wattanaruangkowit P, Panyakhamlerd K., The combination of body mass index and age as a new index for identifying osteoporosis in Thai postmenopausal women. J Med Assoc Thai. 2010; 93 (Suppl 7): S76-82.
28. Lacroix AZ, Buist DS, Brenneman SK, Abbott TA III., Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care. 2005; 43: 293-302.
29. Wei GS, Jackson JL., Postmenopausal bone density referral decision rules: correlation with clinical fractures. Mil Med. 2004; 169: 1000-4.
30. Morin S, Tsang JF, Leslie WD., Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int. 2009; 20: 363-70.
31. Tanaka S, Yoshimura N, Kuroda T, Hosoi T, Saito M, Shiraki M., The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women-a joint analysis of the Nagano, Miyama, and Taiji Cohorts. Bone. 2010; 47: 1064-70.
32. Cheung EY, Bow CH, Cheung CL, Soong C, Yeung S, Loong C, Kung A., Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women. Osteoporos Int. 2012; 23: 871-8.
33. Tamaki J, Iki M, Kadowaki E, Sato Y, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H., Fracture risk prediction using FRAX(R): a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2011; 22: 3037-45.
34. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int. 2011; 22: 839-47.
35. Leslie WD, Lix LM., Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system. J Bone Miner Res. 2011; 26: 460-7.
36. Leslie WD, Tsang JF, Lix LM., Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res. 2009; 24: 353-60.
37. Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A, Lentle BC, Levesque J, Lyons DJ, Tarulli G, Brown JP., Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J. 2005; 56: 178-88.
38. Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J., Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007; 298: 2389-98.
39. Ettinger B, Hillier TA, Pressman A, Che M, Hanley DA., Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt). 2005; 14: 159-71.
40. Hippisley-Cox J, Coupland C., Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012; 344: e3427.
41. Dargent-Molina P, Piault S, Breart G., A comparison of different screening strategies to identify elderly women at high risk of hip fracture: results from the EPIDOS prospective study. Osteoporos Int. 2003; 14: 969-77.
42. Barr RJ, Stewart A, Torgerson DJ, Seymour DG, Reid DM., Screening elderly women for risk of future fractures-participation rates and impact on incidence of falls and fractures. Calcif Tissue Int. 2005; 76: 243-8.
43. Rud B, Hilden J, Hyldstrup L, Hrobjartsson A., Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review. Osteoporos Int. 2007; 18: 1177-87.
44. Steurer J, Haller C, Hauselmann H, Brunner F, Bachmann LM., Clinical value of prognostic instruments to identify patients with an increased risk for osteoporotic fractures: systematic review. PLoS One. 2011; 6: e19994.
45. Szklo M., Population-based cohort studies. Epidemiol Rev. 1998; 20: 81-90.
46. Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD., The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?. J Bone Miner Res. 2010; 25: 2101-7.
47. Lynn P., The problem of nonresponse. In:, De Leeuw ED, Hox JJ, Dillman DD, editors. International handbook of survey methodology. New York: Lawrence Erlbaum Associates; 2008. p. 35-55.
48. Rubin KH, Abrahamsen B, Hermann AP, Bech M, Gram J, Brixen K., Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates. Scand J Public Health. 2011; 39: 312-8.
49. Ensrud KE, Lui LY, Taylor BC, Schousboe JT, Donaldson MG, Fink HA, Cauley JA, Hillier TA, Browner WS, Cummings SR., A comparison of prediction models for fractures in older women: is more better?. Arch Intern Med. 2009; 169: 2087-94.
50. Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O., An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001; 12: 519-28.
51. Langsetmo L, Nguyen TV, Nguyen ND, Kovacs CS, Prior JC, Center JR, Morin S, Josse RG, Adachi JD, Hanley DA, Eisman JA., Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CMAJ. 2011; 183: E107-14.
52. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM., Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332: 767-73.
53. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM., Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008; 149: 889-97.
54. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD., Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005; 58: 475-83.
55. McLeod KM, Johnson CS., Identifying women with low bone mass: a systematic review of screening tools. Geriatr Nurs. 2009; 30: 164-73.
56. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y., Chapter 10: Analysing and presenting results. In:, Deeks JJ, Bossuyt PM, Gatsonis C, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy, version 1.0 [Internet] The Cochrane Collaboration; 2010. [cited 2013 Apr 16]. Available from:http://srdta.cochrane.org
57. Wehren LE, Siris ES., Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis?. J Intern Med. 2004; 256: 375-80.
58. Hanley JA, McNeil BJ., The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143: 29-36.
59. Kanis JA, Oden A, Johansson H, McCloskey E., Pitfalls in the external validation of FRAX. Osteoporos Int. 2012; 23: 423-31.
60. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW., Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010; 21: 128-38.
61. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B., Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001; 12: 989-95.
62. Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ 3rd, Pols HA, Reeve J, Silman AJ, Tenenhouse A., A family history of fracture and fracture risk: a meta-analysis. Bone. 2004; 35: 1029-37.
63. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A., A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004; 35: 375-82.
64. Collins GS, Mallett S, Altman DG., Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ. 2011; 342: d3651.
65. Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui LY, Vesco KK, Black DM, Donaldson MG, Leblanc ES, Cummings SR., WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?. J Bone Miner Res. 2011; 26: 1774-82.
66. Tremollieres FA, Pouilles JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P., Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res. 2010; 25: 1002-9.
67. Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR., FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res. 2009; 24: 1793-9.
68. Machado P, Da Silva JA., Performance of decision algorithms for the identification of low bone mineral density in Portuguese postmenopausal women. Acta Reumatol Port. 2008; 33: 314-28.
69. Gourlay ML, Powers JM, Lui LY, Ensrud KE., Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older. Osteoporos Int. 2008; 19: 1175-83.
70. Martinez-Aguila D, Gomez-Vaquero C, Rozadilla A, Romera M, Narvaez J, Nolla JM., Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit. J Rheumatol. 2007; 34: 1307-12.
71. Harrison EJ, Adams JE., Application of a triage approach to peripheral bone densitometry reduces the requirement for central DXA but is not cost effective. Calcif Tissue Int. 2006; 79: 199-206.
72. Chan SP, Teo CC, Ng SA, Goh N, Tan C, Deurenberg-Yap M., Validation of various osteoporosis risk indices in elderly Chinese females in Singapore. Osteoporos Int. 2006; 17: 1182-8.
73. D'Amelio P, Tamone C, Pluviano F, Di Stefano M, Isaia G., Effects of lifestyle and risk factors on bone mineral density in a cohort of Italian women: suggestion for a new decision rule. Calcif Tissue Int. 2005; 77: 72-8.
74. Gourlay ML, Miller WC, Richy F, Garrett JM, Hanson LC, Reginster JY., Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years. Osteoporos Int. 2005; 16: 921-7.
75. Rud B, Jensen JE, Mosekilde L, Nielsen SP, Hilden J, Abrahamsen B., Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry. Osteoporos Int. 2005; 16: 764-72.
76. Cook RB, Collins D, Tucker J, Zioupos P., Comparison of questionnaire and quantitative ultrasound techniques as screening tools for DXA. Osteoporos Int. 2005; 16: 1565-75.
77. Mauck KF, Cuddihy MT, Atkinson EJ, Melton LJ 3rd., Use of clinical prediction rules in detecting osteoporosis in a population-based sample of postmenopausal women. Arch Intern Med. 2005; 165: 530-6.
78. Wallace LS, Ballard JE, Holiday D, Turner LW, Keenum AJ, Pearman CM., Evaluation of decision rules for identifying low bone density in postmenopausal African-American women. J Natl Med Assoc. 2004; 96: 290-6.
79. Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E, Melton ME, Turpin J, Byrnes C, Ross P., Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc. 2002; 77: 629-37.
80. Cadarette SM, Jaglal SB, Murray TM, McIsaac WJ, Joseph L, Brown JP., Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA. 2001; 286: 57-63.
81. Cass AR, Shepherd AJ, Carlson CA., Osteoporosis risk assessment and ethnicity: Validation and comparison of 2 clinical risk stratification instruments. J Gen Intern Med. 2006; 21: 630-5.
82. Shepstone L, Fordham R, Lenaghan E, Harvey I, Cooper C, Gittoes N, Heawood A, Peters T, O'Neill T, Torgerson D, Holland R, Howe A, Marshall T, Kanis J, McCloskey E., A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Osteoporos Int. 2012; 23: 2507-15.
83. Schneider DL, Worley K, Beard MK, Iannini M, Ko M, McCallum J, Pulicharam R, Steinbuch M., The primary care osteoporosis risk of fracture screening (POROS) study: design and baseline characteristics. Contemp Clin Trials. 2010; 31: 336-44.
84. Weinstein L, Ullery B., Identification of at-risk women for osteoporosis screening. Am J Obstet Gynecol. 2000; 183: 547-9.
85. Michaelsson K, Bergstrom R, Mallmin H, Holmberg L, Wolk A, Ljunghall S., Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int. 1996; 6: 120-6.
86. Cadarette SM, McIsaac WJ, Hawker GA, Jaakkimainen L, Culbert A, Zarifa G, Ola E, Jaglal SB., The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004; 15: 361-6.
87. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Belle Mead, NJ: Excerpta Medica Inc; 1999.
88. Salaffi F, Silveri F, Stancati A, Grassi W., Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol. 2005; 24: 203-11.
89. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV., Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000; 162: 1289-94.
90. Richy F, Gourlay M, Ross PD, Sen SS, Radican L, De Ceulaer F, Ben Sedrine W, Ethgen O, Bruyere O, Reginster JY., Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. QJM. 2004; 97: 39-46.
91. Sedrine WB, Chevallier T, Kvasz A, Micheletti MC, Gelas B, Reginster JY., Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecol Endocrinol. 2002; 16: 245-50.
92. Horner K, Karayianni K, Mitsea A, Berkas L, Mastoris M, Jacobs R, Lindh C, van der Stelt P, Marjanovic E, Adams J, Pavitt S, Devlin H., The mandibular cortex on radiographs as a tool for osteoporosis risk assessment: the OSTEODENT Project. J Clin Densitom. 2007; 10: 138-46.
93. Reginster JY, Ben SW, Viethel P, Micheletti MC, Chevallier T, Audran M., Validation of OSIRIS, a prescreening tool for the identification of women with an increased risk of osteoporosis. Gynecol Endocrinol. 2004; 18: 3-8.
94. Minnock E, Cook R, Collins D, Tucker J, Zioupos P., Using risk factors and quantitative ultrasound to identify postmenopausal Caucasian women at risk of osteoporosis. J Clin Densitom. 2008; 11: 485-93.
95. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, Huang QR, Rajatanavin R, Tsai KS, Park HM, Reginster JY., A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001; 12: 699-705.
96. Pongchaiyakul C, Nguyen ND, Eisman JA, Nguyen TV., Clinical risk indices, prediction of osteoporosis, and prevention of fractures: diagnostic consequences and costs. Osteoporos Int. 2005; 16: 1444-50.
97. Li-Yu JT, Llamado LJ, Torralba TP., Validation of OSTA among Filipinos. Osteoporos Int. 2005; 16: 1789-93.
98. Geater S, Leelawattana R, Geater A., Validation of the OSTA index for discriminating between high and low probability of femoral neck and lumbar spine osteoporosis among Thai postmenopausal women. J Med Assoc Thai. 2004; 87: 1286-92.
99. Park HM, Sedrine WB, Reginster JY, Ross PD., Korean experience with the OSTA risk index for osteoporosis: a validation study. J Clin Densitom. 2003; 6: 247-50.
100. Kung AW, Ho AY, Sedrine WB, Reginster JY, Ross PD., Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis. Osteoporos Int. 2003; 14: 716-21.
101. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C., Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care. 1998; 4: 37-48.
102. Smeltzer SC, Zimmerman VL., Usefulness of the SCORE index as a predictor of osteoporosis in women with disabilities. Orthop Nurs. 2005; 24: 33-9.
103. Brenneman SK, Lacroix AZ, Buist DS, Chen YT, Abbott TA 3rd., Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis. Dis Manag. 2003; 6: 159-68.
104. Cadarette SM, Jaglal SB, Murray TM., Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry. Osteoporos Int. 1999; 10: 85-90.
105. Von Mühlen D, Visby Lunde A, Barrett-Connor E, Bettencourt R., Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in older Caucasian women: the Rancho Bernardo study. Osteoporos Int. 1999; 10: 79-84.
106. Falasca GF, Dunston C, Banglawala YA., Further validation of a questionnaire to identify women likely to have low bone density. J Clin Densitom. 2003; 6: 231-6.
107. Karkucak M, Capkin E, Kerimoglu S, Serdaroglu M, Topbas M, Yildiz H, Guler M., Performance of simple calculated osteoporosis risk estimation in a sample of women with suspected osteoporosis in the Turkish population. Rheumatol Int. 2008; 28: 825-30.
108. Ben SW, Devogelaer JP, Kaufman JM, Goemaere S, Depresseux G, Deroisy R, Reginster JY., Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium. Bone. 2001; 29: 374-80.
109. Colon-Emeric CS, Pieper CF, Artz MB., Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int. 2002; 13: 955-61.
110. Albertsson DM, Mellstrom D, Petersson C, Eggertsen R., Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Ann Fam Med. 2007; 5: 48-56.
111. Albertsson D, Mellstrom D, Petersson C, Thulesius H, Eggertsen R., Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study. BMC Musculoskelet Disord. 2010; 11: 55.
112. Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD., Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int. 2011; 22: 829-37.
113. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA., Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. 2010; 25: 2350-8.
114. Gonzalez-Macias J, Marin F, Vila J, Diez-Perez A., Probability of fractures predicted by FRAX(R) and observed incidence in the Spanish ECOSAP Study cohort. Bone. 2012; 50: 373-7.
115. Ahmed LA, Schirmer H, Fonnebo V, Joakimsen RM, Berntsen GK., Validation of the Cummings' risk score; how well does it identify women with high risk of hip fracture: the Tromso Study. Eur J Epidemiol. 2006; 21: 815-22.
116. van Staa TP, Geusens P, Kanis JA, Leufkens HGM, Gehlbach S, Cooper C., A simple clinical score for estimating the long-term risk of fracture in post-menopausal women. QJM. 2006; 99: 673-82.
117. Hundrup YA, Jacobsen RK, Andreasen AH, Davidsen M, Obel EB, Abrahamsen B., Validation of a 5-year risk score of hip fracture in postmenopausal women. The Danish Nurse Cohort Study. Osteoporos Int. 2010; 21: 2135-42.